Managing risks: A closer look at the legislative proposals on pharmacovigilance, Brussels

Atomium in Brussel
© Kevin Bergenhenegouwen
date January 27, 2010 12:30 - 15:00
city Brussels, Belgium
location European Parliament - József Antall building , Room 6Q1 60, rue Wiertz -1047 Brussels Show location
attending (Antonyia) Parvanova i, (Philippe) Juvin i, (Michèle) Rivasi i et al.
organisation Greens/European Free Alliance (Greens/EFA) i

Expert meeting

European Parliament - Brussels

Wednesday 27 January 2010 12:30–15:00

European Parliament - József Antall building , Room 6Q1

60, rue Wiertz -1047 Brussels

Video documentation

A public meeting hosted and chaired by MEP Rapporteurs Linda Mc Avan (S&D) and Michèle Rivasi (Greens/EFA) and co-hosted by MEPs Philippe Juvin (PPE) and Antonyia Parvanova (ALDE)

PROGRAMME

 
 

Wednesday 27 January 2010  12:30-15:00

 

12:00–12:30

Registration

13:00–13:10 

 Introduction

by the Chairs, MEP Linda Mc Avan and MEP Michèle Rivasi

13:10–13:20 

 Medicines' Adverse Reactions are a public health issue: a proactive approach is needed

Prof. Joan-Ramon Laporte, Catalan Institute of Pharmacology (ICF), Spain

13:20 –13:30 

How to deal with adverse drug reactions reports? The role of National and  regional pharmacovigilance centres

Dr. Thomas Stammschulte, German Medical Association (Arzneimittelkommission der deutschen Ärzteschaft, akdä), Germany

13:30-13:45

The European Commission's Pharmacovigilance proposals: more than a technical issue

Florence Vandevelde, Medicines in Europe Forum

13:45-13:55

Direct patient reporting: what works and why it matters. Findings of an international survey

Prof. Andrew Herxheimer, UK Cochrane Collaboration, United-Kingdom

13:55-14:05

Access to pharmacovigilance information – Patients and consumers' demands

Interventions from:

Martine Van Hecke, Belgian Consumers' Organisation Test-Achats

Ilaria Passarani, European Consumers' Organisation BEUC

14:05-14:15

Comments by the co-chairs, MEP Philippe Juvin and MEP Antonyia Parvanova

14:15-14:45

Open discussion moderated by MEP Michèle Rivasi

14:45-15:00

Conclusion by the MEPs

Simultaneous translation will be available in English and French

Light lunch and refreshments will be available before the start of the meeting at 12:30h

An overflow room will be available with live broadcast of the meeting

This event is facilitated by:

The Greens/EFA in the European Parliament,Association Internationale de la Mutualité (AIM), European Consumers' Organisation (BEUC), Health Action International (HAI) Europe, the International Society of Drug Bulletins (ISDB) and Medicines in Europe Forum (MiEF).


1.

More about...